The Morning BluntVolume 4|Issue 7 December 7, 2018
Marijuana Moment // 12.6.18
Thursday the US Surgeon General Jerome Adams voiced his concerns over marijuana’s Schedule 1 status. Adams says the status inhibits researchers from studying marijuana. Adams, who has previously stated his support for medical research on cannabis, made the comment at a Police Assisted Addiction Recovery Initiative conference in Massachusetts.
The Morning BluntVolume 4|Issue 6 December 6, 2018
ScienceScientists fear that the rapid legalization of marijuana will cause a blind eye to be turned to the environmental impacts of large-scale cultivation. Many pesticides are legal for use in production, and there is little to no regulation about disposal of contaminated water, meaning that is infiltrating the clean water supply for North America. Scientists are urging legislature to consider the impact that the marijuana industry has on water quality and the long-term effects of releasing pesticides into the volatile ecosystem.
The Morning BluntVolume 4|Issue 5 December 5, 2018
ScienceDr Michael Moskowitz, President of the Cannabis Research Consortium of Marin (County), studies THCV (tetrahyrdocannabivarin), one of the rarest and most medically beneficial cannabinoids found in cannabis plants. THCV acts as an anti-inflammatory, anti-epileptic, anti-nausea, and anti-anxiety agent, with little to no harmful side effects. Moskowitz’s research aims to promote and commercialize the medicinal benefits of THCV, similar to the rising popularity of CBD. Seth Wong, President, TEQ Analytical, gave a lecture at The Science of Cannabis Online Symposium 2018. Wong goes into the detailed sampling requirements for the cannabis industry in Colorado and covers sampling procedure and regulation in cultivation and processing facilities. The report discusses at length the troubles with sample heterogeneity and what better practices can do to overcome these challenges. Columbia Care has teamed up with Columbia University to research and compare the active ingredients in cannabis products with the active ingredients in opioids in the only nationally funded study in the country. This project will expand on a former study by Columbia Care which proved that patients being treated with opioids reportedly decreased or stopped opioid use while using medicinal cannabis. CEO of Columbia Care wants to change the way scientists and policy makers view medical cannabis. Blockchain technology tries to offer solutions to the cash-centric nature of the cannabis industry and the lack of supply chain tracking and regulation. Over the next 3-4 years, crypto-currency and plant to product tracking using blockchain will be tested out in the industry.
The Morning BluntVolume 4|Issue 4 December 4, 2018
The Morning BluntVolume 4|Issue 3 December 3, 2018
The Morning BluntVolume 3|Issue 30 November 30, 2018
The Morning BluntVolume 3|Issue 29 November 29, 2018
Redfund Backed Biolog Partners with Cannabis Strategic Ventures to Develop Water Soluble Cannabis TechnologiesBiolog Inc., backed by Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF), and Cannabis Strategic Ventures Inc. (OTC: NUGS) announced a partnership to develop water soluble cannabis technologies for the food and beverage and consumer industries.
The Morning BluntVolume 3|Issue 27 November 27, 2018
The Morning BluntVolume 3|Issue 26 November 26, 2018
“The best way to predict the future is to create it.”
ScienceResearchers Identify Genes for Cannabinoids Though the cannabis genome was sequenced in 2011, teams of US and Canadian researchers have finally located the genes responsible for THC and CBD levels. The genes were found amid DNA deposited in the plant’s genome by viruses during its evolution, leaving researchers to conclude that these genes were possibly evolutionarily created as a result of viral exposure. Advanced Extraction Systems Looking to Expand With the Industry Advanced Extraction Systems Inc., a firm focused on manufacturing and selling oil extraction equipment to the cannabis and hemp industry, is expanding to meet the needs of the growing industry. Advanced Extraction Systems is designing a two-by-1,000 liter system that is expandable to four-by-1,000 liters and can process 3,500 kilograms of cannabis per day. The Endocannabinoid System & Appetite The endocannabinoid system is one of many biological methods the body employs to trigger hunger or fullness. The endocannabinoid system interacts with marijuana and often gives the consumer the munchies. According to Lab Roots’ Amy Loriaux if a substance, like marijuana, can affect physiological systems like appetite, it points to a system that regulates appetite. Take a closer look at how cannabis impacts appetite and the endocannabinoid system. Conducting Research Under Federal Regulation The National Center for Complementary and Integrative Health, at the National Institutes of Health, is sponsoring a workshop on Dec. 8, 2018 to discuss the issues related to conducting research on cannabinoids under the current regulatory framework. The event will bring together researchers, government officials, and industry representatives to foster collaborations for future research opportunities.
The Morning BluntVolume 3| Issue 16 November 16, 2018
“Don’t let yesterday take up too much of today.“